Quality

GMP Quality

The deepest technical layer of this site, and the one everything else is built on. Quality systems, deviations and CAPA, data integrity, validation and inspection readiness — explained in plain English, with the failure modes a definition alone will not tell you, and cited against primary regulation.

Why it reaches you

The technical GMP reference for the people who have to run the system, not just describe it.

Quality carries an unusual burden: accountable for an outcome that depends on decisions taken elsewhere. Release date pressure comes from commercial. Headcount comes from finance. Equipment comes from engineering. The finding, when it lands, lands here.

That is why this section is built around what actually goes wrong rather than what the regulation says in the abstract. Most sites know the requirement. What is scarcer is a clear read on which gap carries genuine exposure, which is tolerable for another quarter, and how to make that argument to people who do not work in quality.

Nothing here is a substitute for your own judgement applied to your own site, product and market. It is a reference and a starting point for that judgement.

What you are accountable forWhere GMP lands on this desk specifically.
The quality system actually working
Not that procedures exist, but that deviations close, CAPAs hold, changes get assessed and the connections between them function.
Demonstrability under inspection
Being able to show control at inspection pace. Most sites fail on retrieval and consistency rather than on underlying compliance.
Product and patient risk
Impact assessment that reaches beyond the batch in front of you to everything sharing the same cause.
Making the case for resource
Translating exposure into terms finance and operations will fund — which is a quality skill, not a commercial one.
Early signalsThese appear in data you already have, before anyone external sees them.

What to watch, in your own reporting

Investigation cycle time rising

Read by inspectors as a proxy for whether the quality system is under control. Each unclosed investigation raises the chance of recurrence.

Retraining recurring as a CAPA action

A documented pattern of ineffective corrective action, visible in your own records before anyone else reads it.

Self-inspection behind schedule

An explicit EU GMP expectation. A programme visibly behind invites scrutiny of everything else.

Audits that never find anything

Usually evidence about auditor independence rather than about site health.

Questions worth askingIf any of these cannot be answered without a project, that is itself the answer.

Six questions that surface exposure early

  1. 01Which two domains carry most of our inspection exposure right now?
  2. 02How many CAPAs closed in the last year had an effectiveness criterion defined before implementation?
  3. 03If an inspector asked for a named operator's training record against a named batch, how long would it take?
  4. 04How often does 'retraining' appear as the action in our deviation log?
  5. 05Who reviews our audit trails, how often, and what did they find last time?
  6. 06Which of our validated processes has drifted since it was validated, and how would we know?
TopicsEach article carries the requirement, the failure modes, and the primary source.

The technical reference, by section

GMP Decision CenterStart from the problem rather than from the service list.

What GMP challenge are you facing?

Next step

Find out where the quality system actually stands

Twenty questions across seven domains, weighted, with your two weakest areas named. It calculates in your browser and submits nothing.